V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 160016019 | 160007944 | 0 | 18.2 | Neo-adjuvant (N) | 2018-08-12 | 2018-08-19 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100004212 |
| 160016020 | 160007945 | 1.75 | 77.3 | Palliative (P) | 2016-05-17 | 2016-05-18 | EW EuroEwing 2012 Arm A VIDE | 02 | N | PEMETREXED | 101663128 |
| 160016022 | 160007946 | null | 53.55 | 03 | 2017-01-11 | 2017-01-11 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100205068 |
| 160016023 | 160007947 | 1.65 | 66 | null | 2020-03-06 | 2020-03-07 | DOXORUBICIN | 02 | N | DOXORUBICIN | 101518178 |
| 160016026 | 160007948 | 1.63 | 89.8 | Palliative (P) | 2016-10-18 | 2016-11-02 | Doxorubicin 75mg/m2 | 02 | N | DOXORUBICIN + IFOSFAMIDE | 101127842 |
| 160016031 | 160007949 | 1.82 | 85 | Palliative (P) | 2018-03-07 | 2018-03-22 | Cisplatin + Pemetrexed | null | N | CISPLATIN + PEMETREXED | 100087288 |
| 160016033 | 160007950 | 1.55 | 99.9 | Palliative (P) | 2017-07-26 | 2017-08-02 | IPM | N | N | BEVACIZUMAB | 101320679 |
| 160016036 | 160007952 | 1.67 | 70.3 | Palliative (P) | 2021-10-21 | 2021-11-15 | null | 02 | N | CARBOPLATIN + PACLITAXEL | 100744831 |
| 160016037 | 160007953 | 1.68 | 86.6 | Palliative (P) | 2017-06-11 | 2017-06-17 | CISPLATIN + IFOSFAMIDE + PACLITAXEL | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 100627735 |
| 160016038 | 160007954 | 1.63 | 64 | Palliative (P) | 2017-02-27 | 2017-02-28 | CARBOPLATIN | 02 | N | CARBOPLATIN | 101849043 |
| 160016039 | 160007955 | 1.6 | 75.4 | Disease modification (D) | 2016-09-06 | 2016-09-17 | Trabectedin | 02 | N | CRIZOTINIB | 101522556 |
| 160016040 | 160007956 | 1.91 | 76.65 | Palliative (P) | 2018-04-22 | 2018-05-07 | Cisplatin + Pemetrexed | N | N | CISPLATIN + PEMETREXED | 101777632 |
| 160016044 | 160007957 | 1.79 | 67.6 | Curative (C) | 2017-08-12 | 2017-08-17 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101273053 |
| 160016045 | 160007958 | 1.74 | 78.65 | Palliative (P) | 2018-05-27 | 2018-06-04 | Bevacizumab 7.5mg/kg | N | N | IVA | 100837130 |
| 160016048 | 160007959 | 1.8 | 24.4 | null | 2018-04-20 | 2018-05-25 | Doxorubicin 75mg/m2 | 02 | N | DOXORUBICIN | 101423414 |
| 160016052 | 160007960 | 1.57 | 74 | Palliative (P) | 2018-05-26 | 2018-06-07 | Carboplatin AUC 6 - 10 | N | N | CARBOPLATIN | 100469429 |
| 160016053 | 160007961 | 1.73 | 75.8 | Palliative (P) | 2016-11-10 | 2016-12-06 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100007149 |
| 160016054 | 160007962 | 1.68 | 79 | Curative (C) | 2019-08-01 | 2019-08-09 | CISPLATIN + IFOSFAMIDE + PACLITAXEL | N | N | ABIRATERONE | 101490712 |
| 160016056 | 160007963 | 1.72 | 75 | Palliative (P) | 2019-11-23 | 2019-12-01 | Liposomal Doxorubicin (20mg/m2) | 02 | N | STS RHABDOMYOSARCOMA RMS 2005 IVAVV | 100887728 |
| 160016059 | 160007964 | 1.81 | 64 | Palliative (P) | 2017-02-10 | 2017-02-22 | LANREOTIDE | null | N | DOXORUBICIN + IFOSFAMIDE | 101423964 |
| 160016061 | 160007965 | 1.74 | 73.9 | Palliative (P) | 2019-03-16 | 2019-03-22 | STS Rhabdomyosarco RMS 2005 IVADoVV | 02 | N | DOXORUBICIN + IFOSFAMIDE | 100809679 |
| 160016063 | 160007966 | 1.6 | 64.2 | Palliative (P) | 2019-03-08 | 2019-03-20 | Ifosfamide | 02 | N | BEVACIZUMAB + CARBO + PACLITAXEL | 100191471 |
| 160016068 | 160007967 | 0 | 65 | Curative (C) | 2017-09-18 | 2017-09-19 | Doxorubicin + Olaratumab | 02 | N | TRIAL UNSPECIFIED | 101614337 |
| 160016070 | 160007968 | 1.79 | 78.5 | Neo-adjuvant (N) | 2013-09-02 | 2013-09-04 | Doxorubicin 75mg/m2 | 02 | N | PACLITAXEL | 101733493 |
| 160016071 | 160007969 | 1.68 | 76.6 | null | 2019-09-08 | 2019-09-11 | BEVACIZUMAB + CARBO + PACLITAXEL | 02 | N | STS RHABDOMYOSARCOMA RMS 2005 IVA | 101610285 |
| 160016072 | 160007970 | 0 | 0 | null | 2017-10-25 | 2017-10-30 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | CARBOPLATIN + PACLITAXEL | 100999312 |
| 160016074 | 160007971 | 1.56 | 47.6 | 03 | 2018-08-09 | 2018-08-26 | CARBOPLATIN + PACLITAXEL | 02 | N | CARBOPLATIN + PACLITAXEL | 100243673 |
| 160016077 | 160007972 | 1.72 | 91 | Palliative (P) | 2020-04-17 | 2020-04-21 | LANREOTIDE | 02 | N | CARBOPLATIN | 100212956 |
| 160016079 | 160007973 | 1.66 | 69.2 | Palliative (P) | 2017-06-04 | 2017-06-18 | CARBOPLATIN + ETOPOSIDE | N | N | ICON8B TRIAL | 101778619 |
| 160016081 | 160007974 | 1.68 | 84.2 | Curative (C) | 2019-08-06 | 2019-08-17 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101388009 |
| 160016087 | 160007975 | 1.76 | 92.65 | Palliative (P) | 2020-06-23 | 2020-06-30 | VIDE | N | N | DOXORUBICIN + OLARATUMAB | 101135772 |
| 160016096 | 160007978 | 1.7 | 53.1 | Palliative (P) | 2019-08-04 | 2019-08-06 | CISPLATIN + ETOPOSIDE | null | null | CAPECITABINE | 100818934 |
| 160016097 | 160007979 | 1.55 | 73.2 | Palliative (P) | 2017-04-20 | 2017-05-08 | Carboplatin AUC 2 - 5 | 02 | N | CARBOPLATIN | 101123853 |
| 160016099 | 160007980 | 1.65 | 40 | null | 2018-07-22 | 2018-07-22 | Carboplatin AUC 6 - 10 | 02 | N | CARBOPLATIN | 100821677 |
| 160016100 | 160007981 | 1.68 | 63.9 | Neo-adjuvant (N) | 2018-10-13 | 2018-10-28 | Doxorubicin + Ifosfamide | 02 | N | GEMCITABINE | 100759151 |
| 160016101 | 160007982 | 1.84 | 45 | Neo-adjuvant (N) | 2018-11-29 | 2018-11-29 | Docetaxel 75mg/m2 (21 day) | 02 | N | VINORELBINE | 101733720 |
| 160016102 | 160007983 | 1.64 | 67 | Neo-adjuvant (N) | 2019-04-14 | 2019-04-24 | CARBOPLATIN + PACLITAXEL | N | N | CARBOPLATIN + PACLITAXEL | 100224260 |
| 160016104 | 160007984 | 1.68 | 62.1 | Palliative (P) | 2017-02-26 | 2017-02-26 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101862128 |
| 160016107 | 160007985 | 1.88 | 156 | Palliative (P) | 2018-02-27 | 2018-03-28 | EW EuroEwing 2012 Arm B VDC | N | N | DOXORUBICIN + IFOSFAMIDE | 101313962 |
| 160016111 | 160007986 | 1.78 | 45 | Curative (C) | 2017-03-24 | 2017-03-28 | Doxorubicin + Ifosfamide | Y | N | LIPOSOMAL DAUNORUBICIN | 100855272 |
| 160016115 | 160007987 | 1.61 | 22.3 | null | null | 2019-03-17 | Trial Unspecified | N | N | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 101555413 |
| 160016118 | 160007988 | null | null | Palliative (P) | 2020-04-08 | 2020-04-08 | STS Rhabdomyosarco RMS 2005 IVADoVV | 02 | null | DOXORUBICIN + OLARATUMAB | 101008628 |
| 160016120 | 160007989 | 1.76 | 90.1 | Neo-adjuvant (N) | 2018-11-07 | 2018-11-07 | ICON8B TRIAL | null | N | TRIAL UNSPECIFIED | 101614220 |
| 160016121 | 160007990 | 1.72 | 75.6 | null | 2018-06-30 | 2018-07-06 | Cyclophosphamide oral | 02 | N | ATOMIC-MESO TRIAL | 100093224 |
| 160016122 | 160007991 | 1.68 | 75 | Palliative (P) | 2019-04-06 | 2019-04-13 | MELPHALAN | N | N | STS RHABDOMYOSARCO RMS 2005 IVADOVV | 100365512 |
| 160016124 | 160007992 | 1.73 | 95.7 | Curative (C) | 2018-06-23 | 2018-06-26 | TEMOZOLOMIDE | 02 | N | STS NON-RHABDO EPSSG 2005 VDCY | 101007495 |
| 160016126 | 160007993 | 1.57 | 70 | Palliative (P) | null | 2019-06-13 | Doxorubicin 75mg/m2 | 02 | N | DOXORUBICIN | 100019798 |
| 160016128 | 160007994 | 1.91 | 104 | Palliative (P) | 2020-05-06 | 2020-05-14 | Liposomal Doxorubicin (Caelyx) | 02 | N | CARBOPLATIN + PACLITAXEL | 101536348 |
| 160016131 | 160007995 | 1.7 | 72.2 | null | 2016-12-08 | 2016-12-13 | Cisplatin + Pemetrexed | 02 | Y | CISPLATIN + PEMETREXED | 101315991 |
| 160016132 | 160007996 | 1.63 | 57.7 | Neo-adjuvant (N) | 2019-04-10 | 2019-04-12 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | CARBOPLATIN + PACLITAXEL | 100122559 |